About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00570752

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

The purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation in atherosclerotic plaque

Lead sponsor: Bristol-Myers Squibb•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•History of documented atherosclerosis
•LDL between 70 and 130 mg/dL
•Patients receiving stable low- to moderate-dose statin
•BMI 18-37 kg/m²
•Must be able to swallow tablets
•Must be able to medically tolerate the procedures, contrast medium, and medications involved

Exclusion Criteria

•Statin intolerance
•Renal impairment (serum creatinine \> 1.5 mg/dL)
•History of chronic viral hepatitis or other liver dysfunction
•Major infection requiring hospitalization or receipt of IV antibiotics due to an infection within 2 months prior to initiation of study treatment

Related studies

Health Ahead Comparative Effectiveness Study

NCT07669168 · Health Services Accessibility, Rural Health, and more

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

RECRUITINGPhase 3

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more

Natural History of Stroke: Cause and Development

NCT00009243 · Brain Disease, Ischemic Attack, Transient, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 7, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment72

Start dateDec 2008

Last updatedDec 7, 2015

Condition

Vascular Diseases

Locations shown

Southeast Clinical Research, Llc

Chiefland, Florida

Jacksonville Center For Clinical Research - Univ Campus

Jacksonville, Florida

Florida Cardiovascular Institute

Tampa, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 7, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions